MICHAEL BRAUN to Middle Aged
This is a "connection" page, showing publications MICHAEL BRAUN has written about Middle Aged.
Connection Strength
0.098
-
Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2034-40.
Score: 0.015
-
Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Am J Kidney Dis. 2011 Feb; 57(2):291-9.
Score: 0.015
-
Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma. Cancer Immunol Immunother. 2010 Jun; 59(6):909-19.
Score: 0.014
-
WEB-only treatment of ruptured and unruptured intracranial aneurysms: a retrospective analysis of 47 aneurysms. Acta Neurochir (Wien). 2019 08; 161(8):1507-1513.
Score: 0.007
-
Health-related quality of life in glomerular disease. Kidney Int. 2019 05; 95(5):1209-1224.
Score: 0.006
-
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. Am J Kidney Dis. 2019 02; 73(2):218-229.
Score: 0.006
-
Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study. Strahlenther Onkol. 2019 Apr; 195(4):289-296.
Score: 0.006
-
Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.005
-
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer. Eur J Cancer. 2014 Dec; 50(18):3136-44.
Score: 0.005
-
Staging of primary breast cancer is not indicated in asymptomatic patients with early tumor stages. Oncol Res Treat. 2014; 37(7-8):400-5.
Score: 0.005
-
Measuring exertion during caregiving of children and young adults with cerebral palsy who require assistance for mobility and self-care. Phys Occup Ther Pediatr. 2013 Aug; 33(3):300-12.
Score: 0.004
-
Changes in Ki-67 labeling indices during neoadjuvant chemotherapy for advanced ovarian cancer are associated with survival. Int J Gynecol Cancer. 2010 May; 20(4):555-60.
Score: 0.003
-
In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer. BMC Cancer. 2010 Apr 13; 10:137.
Score: 0.003
-
Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. Am J Hypertens. 2008 May; 21(5):533-8.
Score: 0.003